For the second Time Bayer has with his daughter Monsanto suffered in court, a defeat. The wave of lawsuits in the US due to glyphosate has only just begun – with incalculable financial risks.
For the second Time, American courts have awarded now with cancer claimants high Millions in damages. And the next process is already available, only a few kilometres from San Francisco in Oakland. It is the disease of a married couple, who both suffer from cancer of the lymph nodes.
What are the effects of these legal decisions have on the Bayer group? Obviously, the share price has come under massive pressure. Bayer is now worth less than it was before the merger with Monsanto. The purchase price of 63 billion dollars vanished practically into thin air.